Metrics as of 10/13/2026, 06:53 PM (Berlin time), refresh in progress.
Incannex Healthcare Stock
Incannex Healthcare Limited
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Australia
- CEO
- Joel Bradley Latham
- Employees
- 12
- Market cap
- $35 M
- IPO
- 02/03/2022
Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound…
Incannex Healthcare stock: price history
1D
+0.3%
1W
-8.2%
1M
-10.7%
6M
-17.8%
YTD
-72.9%
1Y
-76.2%
2Y
-93.9%
5Y
–
10Y
–
Next earnings date
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~163% stronger price swings than usual
Ask the agents about Incannex Healthcare
Incannex Healthcare stock metrics
P/E
-2.6
P/B
0.53
EV/EBITDA
1.44
RETURN ON EQUITY
-19.0%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
82.5%
FLOAT SHARES
9,871,355
AVG. DAILY VOLUME (30D)
84,836
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Incannex Healthcare stock
What does Incannex Healthcare do?
Incannex Healthcare Limited is a company in the Healthcare sector, Biotechnology industry, headquartered in Australia.
The CEO is Joel Bradley Latham, the company employs around 12 people.
The IPO was on 02/03/2022; the stock trades on NASDAQ under the ticker IXHL.
When does Incannex Healthcare report next?
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly 163% stronger than usual.
Does Incannex Healthcare pay a dividend?
No, Incannex Healthcare currently does not pay a dividend.
Which stocks are comparable to Incannex Healthcare?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Incannex Healthcare stock analyzed?
Clicking "Analyze stock" lets five strategies assess Incannex Healthcare against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.